Testing effectiveness (Phase 2)Ended earlyNCT00047333
What this trial is testing
Erlotinib in Treating Patients With Liver Cancer That Cannot be Surgically Removed
Who this might be right for
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer
National Cancer Institute (NCI) 80